A new era in pyrogen testing

被引:105
作者
Ding, JL
Ho, B
机构
[1] Natl Univ Singapore, Dept Sci Biol, Singapore 117543, Singapore
[2] Natl Univ Singapore, Dept Microbiol, Singapore 117543, Singapore
关键词
D O I
10.1016/S0167-7799(01)01694-8
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 0836 [生物工程]; 090102 [作物遗传育种]; 100705 [微生物与生化药学];
摘要
Pyrogens are substances (usually of biological origin) that cause fever after injection. The best-studied pyrogen is lipopolysaccharide (LPS, also known as endotoxin), found in the membrane of Gram-negative bacteria. During Gram-negative sepsis, endotoxin stimulates host macrophages to release inflammatory cytokines and excessive inflammation causes multiple organ failure and death. Endotoxins are thus ubiquitous pathogenic molecules that are a bane to the pharmaceutical industry and medical community. Limulus amoebocyte lysate (LAL) has been widely used for ∼25 years for the detection of endotoxin in quality control of injectable drugs and medical devices. However, variations in sensitivity and specificity of LAL to endotoxin, and the limited supply of limulus (horseshoe crabs) has called for an alternative pyrogen test. Recombinant Factor C (rFC), the endotoxin-inducible coagulation enzyme in LAL, forms the basis of a novel micro-enzymatic assay for high-throughput screens of endotoxin and opens a new era in endotoxin testing. Endotoxin activates the rFC zymogen, which catalytically hydrolyses synthetic substrates to form measurable products, thus quantifying the endotoxin.
引用
收藏
页码:277 / +
页数:5
相关论文
共 61 条
[1]
BANG FB, 1956, B JOHNS HOPKINS HOSP, V98, P325
[2]
BERZOFSKY RN, 1996, BIOWHITTAKER LAL REV
[3]
LIMULUS AMEBOCYTE LYSATE REACTION WITH STREPTOCOCCAL PYROGENIC EXOTOXIN [J].
BRUNSON, KW ;
WATSON, DW .
INFECTION AND IMMUNITY, 1976, 14 (05) :1256-1258
[4]
TYPHOID-FEVER - STUDIES OF BLOOD-COAGULATION, BACTEREMIA, AND ENDOTOXEMIA [J].
BUTLER, T ;
BELL, WR ;
LEVIN, J ;
LINH, NN ;
ARNOLD, K .
ARCHIVES OF INTERNAL MEDICINE, 1978, 138 (03) :407-410
[5]
COOPER JF, 1970, J NUCL MED, V11, P310
[6]
COOPER JF, 1976, B PARENTERAL DRUG AS, V29, P122
[7]
Dabbah R, 1980, J Parenter Drug Assoc, V34, P212
[8]
DAOUST DR, 1976, B PARENTERAL DRUG AS, V31, P13
[9]
Ding Jeak L., 1995, Molecular Marine Biology and Biotechnology, V4, P90
[10]
Ding JL, 1997, J ENDOTOXIN RES, V4, P33, DOI 10.1177/096805199700400105